Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Phase II SBIR grant awarded to 3-D for GPCRs

March 6, 2000

Collaboration between Novartis and Emisphere extended to include second compound

March 3, 2000

Vertex enters genomic partnership with Incyte

March 3, 2000

Successful clinical results with IDEA's drug delivery system trigger payment from P&G

March 2, 2000

Human Genome Sciences and CAT to collaborate on antibody development program

March 2, 2000

Abgenix extends antibody collaboration with Pfizer

Feb. 29, 2000

Vical, Human Genome Sciences and Vascular Genetics form collaboration

Feb. 29, 2000

High-affinity, selective human A3 receptor radioligand: synthesis and preliminary testing

Feb. 28, 2000

Oxford BioMedica to collaborate with AstraZeneca in drug discovery

Feb. 25, 2000

Corixa subscribes to Incyte's LifeSeq Gold database

Feb. 24, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
AAIC 2026: Age of amyloid is being joined by time of tau
BioWorld
The Alzheimer’s Association International Conference (AAIC) is the world’s biggest dementia conference. And at the AAIC 2026 meeting, there is big buzz around...
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...